Records 1-23 (of 23 Records) |
Query Trace: Hiv/aids[original query] |
---|
"Stuck in pandemic uncertainty: A review of the persistent Effects of COVID-19 infection in immune deficient people". Manuelpillai Bevin, et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2024 0 0. |
Quantitatively assessing early detection strategies for mitigating COVID-19 and future pandemics. Andrew Bo Liu et al. Nat Commun 2023 12 (1) 8479 |
Bifurcation and optimal control analysis of HIV/AIDS and COVID-19 co-infection model with numerical simulation. Kotola Belela Samuel, et al. PloS one 2023 0 0. (5) e0284759 |
The COVID-19 Vaccination Still Matters: Omicron Variant Is a Final Wake-Up Call for the Rich to Help the Poor. Rzymski Piotr, et al. Vaccines 2022 0 0. (7) |
Efficacious Preclinical Repurposing of the Nucleoside Analogue Didanosine against COVID-19 Polymerase and Exonuclease. Rabie Amgad M, et al. ACS omega 2022 0 0. (25) 21385-21396 |
Hosting ICASA 2021 in South Africa amidst the global Omicron scare. Moshabela Mosa, et al. The Pan African medical journal 2022 0 0. 91 |
COVID-19 infodemic and digital health literacy in vulnerable populations: A scoping review. Choukou Mohamed-Amine, et al. Digital health 2022 0 0. 20552076221076927 |
Real-Time Infectious Disease Modeling to Inform Emergency Public Health Decision Making. Bershteyn Anna, et al. Annual review of public health 2022 0 0. |
HIV-1 genetic diversity and drug resistance mutations in the northern Brazilian region. Crispim Myuki Esashika, et al. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2021 0 0. 101596 |
Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s). Mohanty Swaraj, et al. Virusdisease 2021 0 0. 1-10 |
An Emerging SARS-CoV-2 Mutant Evades Cellular Immunity and Increases Infectivity Motozono, Chihiro et al. SSRN April 15 2021 |
COVID-19 vaccines and nanomedicine. Shapiro Robert S, et al. International journal of dermatology 2021 0 0. |
Modelling COVID-19 transmission in Africa: countrywise projections of total and severe infections under different lockdown scenarios. Frost Isabel, et al. BMJ open 2021 0 0. (3) e044149 |
Covid-19 deaths in Africa: prospective systematic postmortem surveillance study. Mwananyanda Lawrence, et al. BMJ (Clinical research ed.) 2021 0 0. n334 |
Natural biflavonoids as potential therapeutic agents against microbial diseases. Menezes José C J M D S, et al. The Science of the total environment 2021 1 0. 145168 |
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs. Tompa Dharma Rao, et al. International journal of biological macromolecules 2021 1 0. |
Custommune: a web tool to design personalized and population-targeted vaccine epitopes Tarek, Mohammad et al. medRxiv April 29 2020 |
Adaptation of advanced clinical virology assays from HIV-1 to SARS-CoV-2. McCormick Kevin D, et al. Current opinion in HIV and AIDS 2020 11 0. |
Predicting the Impact of COVID-19 and the Potential Impact of the Public Health Response on Disease Burden in Uganda. Bell David, et al. The American journal of tropical medicine and hygiene 2020 0 0. (3) 1191-1197 |
Pandemics and methodological developments in epidemiology history. Morabia Alfredo, et al. Journal of clinical epidemiology 2020 0 0. 164-169 |
Chemokine receptor gene polymorphisms and COVID-19: Could knowledge gained from HIV/AIDS be important? Mehlotra Rajeev K, et al. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2020 8 0. 104512 |
Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017. Dong Yanhui, et al. BMJ (Clinical research ed.) 2020 0 0. m1043 |
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Clark Andrew et al. The Lancet. Global health 2020 6 (8) e1003-e1017
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study A Clark et al, Lancet Global Health, June 15, 2020 null Coronavirus Coronavirus COVID-19 We estimated that 1?7 billion (UI 1?0?2?4) people, comprising 22% (UI 15?28) of the global population, have at least one underlying condition that puts them at increased risk of severe COVID-19 if infected (ranging from <5% of those younger than 20 years to >66% of those aged 70 years or older).
|
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 21, 2024
- Content source: